Monthly Archives :

June 2023

DAMONA Pharmaceuticals Appoints John Reilly as Chief Executive Officer

DAMONA Pharmaceuticals Appoints John Reilly as Chief Executive Officer 1200 627 Thomas Prevot

TORONTO, June 13, 2023— DAMONA Pharmaceuticals, a preclinical biopharmaceutical company focused on the discovery and development of first-in-class small molecules for the treatment and prevention of cognitive symptoms associated with brain disorders and aging, today announced the appointment of John Reilly as the company’s Chief Executive Officer and member of the Board of Directors. Mr.…

read more